Intralymphatic eASC Administration in Healthy Volunteers

Clinical trial NCT01743222 · COMPLETED

Trial details

NCT number: NCT01743222
Sponsor: Tigenix S.A.U.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Localized Adverse Reaction to Administration of Drug

Start date: 2012-01-01
Primary completion: 2012-05-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.